Thalidomide was one signature away from being sold to pregnant American women. Frances Kelsey stopped it and saved thousands of lives.
The year was 1960. Thalidomide was already the best-selling sleeping pill in Europe, handed out for morning sickness, marketed as completely safe. Its American manufacturer expected a rubber stamp, and the application landed on Kelsey’s desk, one month into her job at the FDA, precisely because it looked easy.
She read the file and something bothered her. “Here was a drug that looked like it should be no problem,” she said later, “but at the same time there was just a feeling that there was something in the data or the absence of data that was a cause of concern.”
Under the law back then, a drug went to market automatically if the FDA didn’t act within sixty days. So she used the one power she had: she asked for more evidence. And when the clock ran down, she asked again. For fourteen months.
The company came at her roughly fifty times, again and again going over her head to her superiors, and finally threatened to sue her for libel. They had the brochures printed and raw material waiting for fifteen million pills. Executives had names for her. “Most of the things they called me, you wouldn’t print,” she recalled. Her own diagnosis was simpler: they “were losing money by my pigheadedness.”
Then the news arrived from Europe. Babies born with devastating birth defects, more than ten thousand of them, everywhere the pill had been sold. In the United States: seventeen cases, traced to samples the company had already handed to doctors as “research.” Not because America was lucky. Because one scientist would not be moved.
On August 7, 1962, sixty-four years ago this week, President Kennedy presented her with the nation’s highest award for civilian service, only the second woman ever to receive it.
“Her exceptional judgment in evaluating a new drug for safety for human use,” the citation read, “has prevented a major tragedy of birth deformities in the United States.” Congress then rewrote the drug laws around her example.
The sixty-day automatic approval died. The “research sample” loophole closed. Proof came before profit, for every pill since.
The modern FDA, the agency standing between your family and the next thalidomide, was built on one woman’s refusal to hurry. She stayed forty-five years.
Sixty-four years later, that is the exact species of public servant this government is driving out.
RFK Jr. fired all seventeen members of the CDC’s vaccine advisory panel in a single day. The CDC director who refused to sign off on his vaccine changes lasted twenty-nine days. The FDA’s top vaccine scientist is gone. And measles, which this country eliminated in 2000, is at 2,371 cases, the most since 1991, with America’s elimination status now under formal review.
They called her stubborn. Difficult.
Thank god they were right.
